drugset / Trial / NCT00860938

Predictor for an Additional Benefit of Inhaled Corticosteroid in Patients Treated With Tiotropium for COPD

NCT00860938

Phase 4 Completed 90 enrolled Cantonal Hosptal, Baselland
RandomizedParallel-groupTriple-blindTreatment

Summary

Study purpose is to evaluate if subjects with chronic obstructive pulmonary disease (COPD) are more likely to be responsive to additional inhaled corticosteroids if they have a positive response to hyperosmolar challenge with mannitol than if their response is negative.

Timeline

Start
2007-04
Primary completion
2010-08
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Budesonide Small molecule 1600 ug Inhaled